DUO XU, M.D.
Ophthalmology Physician · PHILADELPHIA, PA
Individual Active NPI 1992117014
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,699 | 38,035 | $22,078,329 | $6,997,378 | $5,518,758 |
| 2023 | 1,897 | 31,256 | $20,744,445 | $6,737,127 | $5,303,779 |
| 2022 | 1,782 | 21,143 | $16,879,392 | $5,575,656 | $4,397,053 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 10,320 | $34 | $27 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 8,439 | $226 | $180 |
| 92134 | Imaging of retina | 4,638 | $43 | $32 |
| J0178 | Injection, aflibercept, 1 mg | 3,308 | $824 | $656 |
| 67028 | Injection of drug into eye | 3,287 | $136 | $103 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 2,220 | $108 | $86 |
| 92012 | Established patient problem focused exam of visual system | 1,952 | $95 | $70 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,335 | $146 | $116 |
| 92014 | Established patient complete exam of visual system | 708 | $133 | $93 |
| J0177 | Injection, aflibercept hd, 1 mg | 416 | $331 | $264 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 310 | $179 | $128 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 191 | $26 | $20 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | MD463901 | PA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Pennsylvania
- NPI 1861923989
- NPI 1700276391
- NPI 1528352804
- NPI 1659319382
- NPI 1174524771
- NPI 1760131338
- NPI 1922819606
- NPI 1518305242
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.